Skip to content

The influence of intravenous infusion of oxycodone on the quality of postoperative recovery in patients undergoing laparoscopic surgery

The influence of intravenous infusion of oxycodone on the quality of postoperative recovery in patients undergoing laparoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104837
Enrollment
Unknown
Registered
2025-06-24
Start date
2025-06-25
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tumor

Interventions

Control group:Anesthesia induction with 0.1 mg/kg, followed by equivalent-volume normal saline infusion until 1 hour pre-surgical conclusion
Low-dose Oxycodone Group:Anesthesia induction: oxycodone 0.1 mg/kg
maintenance infusion at 0.02 mg/kg/h until 1 hour before surgery completion
High-dose Oxycodone Group:Anesthesia induction: oxycodone 0.1 mg/kg
maintenance infusion at 0.04 mg/kg/h until 1 hour before surgery completion

Sponsors

Anqing Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 68 Years

Inclusion criteria

Inclusion criteria: 1.Patients with complete clinical data who are intended to undergo gynecologic hysteroscopic surgery; 2.The patient's age is 18-68 years old; ASA classification I-?; 3.NYHA Class I-II; 4.Body mass index (BMI) of 17-28 kg/m^2; 5.Clearly understand, voluntarily participate in the study and sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Individuals with a history of alcohol abuse or drug abuse; 2.Opioid-dependent individuals; 3.Patients with accompanying hearing and speech impairments are unable to cooperate with the examiner; 4.Patients with preoperative severe systemic diseases, such as neuropsychiatric disorders, paralytic ileus or acute abdomen, hepatic or renal insufficiency, uncontrolled hypertension, diabetes mellitus, or other organ dysfunction; 5.Recent history of acute upper respiratory tract infection or pulmonary infection; 6.patients during pregnancy or lactation; 7.Preoperative administration of sedatives or analgesics; 8.Those who are allergic to opioids and other anesthetic drugs; 9.The patient or their family members declined to participate in the study;

Design outcomes

Primary

MeasureTime frame
The QoR-15 scale scores and sleep quality scores;

Secondary

MeasureTime frame
Time Statistics Operation time;Postoperative adverse reactions and corrective treatment;Dosage of propofol, remifentanil, cisatracurium, and other adjuvant drugs;Visual Analogue Scale (VAS) Score and Ramsay Sedation Scale (RSS);Hemodynamic Indicators;Postoperative ventilation and defecation time;

Countries

China

Contacts

Public ContactJu Xia

Anqing Municipal Hospital

alcon2006@126.com+86 556 5506332

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026